Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Amit G. Singal(Southwestern Medical Center), Nicole E. Rich(Southwestern Medical Center), Neil Mehta(University of California, San Francisco), Andrea D. Branch(Icahn School of Medicine at Mount Sinai), Anjana Pillai(University of Chicago), Maarouf Hoteit(University of Pennsylvania), Michael L. Volk(Loma Linda University), Mobolaji Odewole(Southwestern Medical Center), Steven Scaglione(Loyola University Medical Center), Jennifer Guy(California Pacific Medical Center), Adnan Said(University of Wisconsin–Madison), Jordan J. Feld(Toronto General Hospital), Binu V. John(Hunter Holmes McGuire VA Medical Center), Catherine Frenette(Scripps Green Hospital), Parvez Mantry, Amol S. Rangnekar(Georgetown University), Omobonike Oloruntoba(Duke University Health System), Michael D. Leise(Mayo Clinic), Janice H. Jou(Oregon Health & Science University), Kalyan Ram Bhamidimarri(University of Miami), Laura Kulik(Northwestern University), George N. Ioannou(University of Washington), Annsa C. Huang(University of California, San Francisco), Tram T. Tran(Cedars-Sinai Medical Center), Hrishikesh Samant(Louisiana State University Health Sciences Center New Orleans), Renumathy Dhanasekaran(Stanford University), Andrés Duarte‐Rojo(University of Arkansas for Medical Sciences), Reena Salgia(Henry Ford Hospital), Sheila Eswaran(Rush University Medical Center), Prasun K. Jalal(Baylor College of Medicine), Avegail Flores(Washington University in St. Louis), Sanjaya K. Satapathy(Northwell Health), Sofia Kagan(Southwestern Medical Center), Purva Gopal(Southwestern Medical Center), Robert J. Wong(Alameda Health System), Neehar D. Parikh(University of Michigan), Caitlin C. Murphy(Southwestern Medical Center)
Gastroenterology
July 30, 2019
Cited by 188Open Access
Full Text

Abstract


Related Papers